Figure 3.
Feedback on knowledge, use and challenges in adoption of RDTs: (A) knowledge about specific technologies for RDTs; (B) percentage of clinicians that had heard about (black) or used (white) RDT for a specific disease—multiple answers possible; and (C) barriers encountered and perceived changes needed in RDTs. The large difference in “reliability” comes from doctors indicating both reliability and standardization, which will make results more reliable, as a change to unreliable RDTs.